All Business articles
View all stories of the same content type.
-
BusinessExplainer: what Silicon Valley Bank’s collapse means for chemistry companies
US and UK-based lender found a niche supporting start-ups - its loss will make it harder for growing companies to access finance
-
Business
New Jersey sues Dow Chemical and others over 1,4-dioxane pollution
US State wants companies to be held accountable for cleaning up widespread contamination
-
Business
Pfizer to buy cancer biotech Seagen for $43 billion
Antibody-drug conjugate specialist will fill Pfizer’s cancer pipeline
-
Business
Fragrance firms face coordinated cartel probe
Givaudan, Firmenich, Symrise and IFF raided by competition authorities
-
Business
US government sues chemical firm over chloroprene emissions
Denka disputes claims of ‘unacceptably high’ releases from neoprene manufacturing facility
-
Business
UK battery industry plans running down as Britishvolt fails
Political uncertainty risks UK losing out to China, US and EU
-
Business
Transforming sawdust with ultrasound
Bio-Sep can break down biomass and extract valuable molecules without damaging them
-
Business
Thousands of jobs to go as chemicals giants cut costs
Dow and 3M laying off a total of 4500 employees worldwide
-
Business
Contaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
Business
J&J subsidiary claims key talc research is fraudulent
Complaint alleges study that helped link talc to cancer contained false information
-
Business
Encoding creativity in drug discovery
Machine learning can complement and reinforce human intuition and experience
-
Business
Merck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
-
Business
Fatal explosion and fire at chemical plant in China
Five dead, a further eight missing, and 30 more injured at Panjin Haoye Chemical
-
Business
ExxonMobil scientists’ climate models were accurate, but hidden
Documents show internal predictions were as good as contemporary science but executives publicly downplayed their significance
-
Business
Second Alzheimer’s antibody approved in the US
Biogen–Eisai’s lecanemab can slow disease progression a little, but at significant cost and risk of side effects
-
Business
3M pledges to exit PFAS manufacturing
Conglomerate will remove fluorochemicals from portfolio in a bid to stay ahead of rapidly tightening regulations
-
Business
Anti-drift additives may volatilise alongside herbicides, causing pollution
Research suggests amine salts could be entering atmosphere, but manufacturers say lab model is unrealistic
-
Business
UK antibiotics supply chain stretched by surge in Strep A infections
Government enacts protocols to enable substitute treatments and recommends preventive prescriptions in severe cases
-
Business
Chemicals industry roundup 2022
Russia’s invation of Ukraine mounted further pressure onto already strained supply chains
-
Business
Pharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
